Skip to content

A Study describing about what happened to patients with long standing kidney disease who got coronavirus during the 2nd wave.

Clinical profile of chronic kidney disease patients with COVID-19 during 2nd wave - A study in a tertiary care centre

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/12/038967
Enrollment
45
Registered
2021-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N189- Chronic kidney disease, unspecified Health Condition 2: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

Kasturba Medical College Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Adult patients aged over 18 years presenting with COVID-19 illness and having underlying Chronic Kidney disease admitted to Kasturba Hospital, Manipal during the COVID-19 2nd wave between 01/03/2021-31/05/2021. Case definitions Persons with chronic kidney disease â?? which is defined by the KDIGO as â??abnormalities in kidney structure or function for 3 months or more with health implications satisfying either of the 2 criteria for CKD (either of the following present for > 3months).â?? A. â??One or more markers of kidney damage namely albuminuria {Urine albumin excretion rate (AER) >30 mg/24 hours; Albumin Creatinine Ratio (ACR) >30 mg/g [ >3 mg/mmol]}, urine sediment abnormalities, electrolyte, and other abnormalities due to tubular disorders, abnormalities detected by histology, structural abnormalities detected by imaging, history of kidney transplantation.â?? B. â??eGFR of AND in whom COVID-19 has been diagnosed using Reverse Transcriptase â?? Polymerase Chain Reaction (RT-PCR) or a rapid antigen test (RAT) have been included in this study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
1. Clinical characteristics and symptomatology of COVID-19 patients with underlying chronic kidney disease at presentation. 2. Initial Laboratory parameters, Chest X-rays at admission, secondary infections which were present apart from the primary COVID-19 disease, and the treatments given. 3. Associations between the clinical characteristics, laboratory parameters, Chest- X-ray severity scores, secondary infections with the complications and final outcomes, and the impact of treatments given. Timepoint: Day 1 after admission and final outcome - death, recovery, or discharged against medical advice

Secondary

MeasureTime frame
1. Clinical characteristics and symptomatology of COVID-19 patients with underlying chronic kidney disease at presentation. 2. Initial Laboratory parameters, Chest X-rays at admission, secondary infections which were present apart from the primary COVID-19 disease, and the treatments given. 3. Associations between the clinical characteristics, laboratory parameters, Chest- X-ray severity scores, secondary infections with the complications and final outcomes, and the impact of treatments given. Timepoint: day 1 and final outcome -death, recovery, or discharged against medical advice

Countries

India

Contacts

Public ContactDr B A SHASTRY

Kasturba Medical College, Manipal

shastryba@yahoo.co.in9845702450

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026